Take the point the reduction in EBIT. It’s not clear how that could happen given the margin is about the same and sales have only dropped by 8%. Either fixed costs have gone up dramatically which wouldn’t make sense either or there has been an impairment of some type. I can only assume it is a non cash impairment which is no big deal given the current share price.
I think the key here is CASH! Up over $4m with $20m closing cash balance. At this price the dividend return looks amazing. Looking forward to seeing the final results next month.
Take the point the reduction in EBIT. It’s not clear how that...
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DSK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.035(2.94%) |
Mkt cap ! $71.91M | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.20 | $1.15 | $169.3K | 144.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 48 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 5883 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| DSK (ASX) Chart |